Myriad Genetics reported $212.8M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.43B 2M Jun/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
Bruker USD 790.5M 21.6M Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Illumina USD 525M 374M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quest Diagnostics USD 2.62B 34M Sep/2026
Quidel USD 606.8M 39.4M Sep/2026
Repligen USD 185.01M 2.01M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Standard Biotools USD 27.93M 2.63M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Veracyte USD 133.73M 7.37M Sep/2026
Waters USD 527M 592M Jun/2026